Recent Finacing
Recent Raise
PPI Pharmaceuticals develops targeted oncology therapeutics using a platform from Dr. Campbell McInnes’s lab to generate compounds specific for molecular tumor targets and limit effects on normal cells.
Recent Investors
Funding round
Investor